Effect of an 18-Month Meditation Training on Regional Brain Volume and Perfusion in Older Adults: The Age-Well Randomized Clinical Trial.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 11 2022
Historique:
pubmed: 11 10 2022
medline: 18 11 2022
entrez: 10 10 2022
Statut: ppublish

Résumé

No lifestyle-based randomized clinical trial directly targets psychoaffective risk factors of dementia. Meditation practices recently emerged as a promising mental training exercise to foster brain health and reduce dementia risk. To investigate the effects of meditation training on brain integrity in older adults. Age-Well was a randomized, controlled superiority trial with blinded end point assessment. Community-dwelling cognitively unimpaired adults 65 years and older were enrolled between November 24, 2016, and March 5, 2018, in France. Participants were randomly assigned (1:1:1) to (1) an 18-month meditation-based training, (2) a structurally matched non-native language (English) training, or (3) no intervention arm. Analysis took place between December 2020 and October 2021. Meditation and non-native language training included 2-hour weekly group sessions, practice of 20 minutes or longer daily at home, and 1-day intensive practices. Primary outcomes included volume and perfusion of anterior cingulate cortex (ACC) and insula. Main secondary outcomes included a global composite score capturing metacognitive, prosocial, and self-regulatory capacities and constituent subscores. Among 137 participants (mean [SD] age, 69.4 [3.8] years; 83 [60.6%] female; 54 [39.4%] male) assigned to the meditation (n = 45), non-native language training (n = 46), or no intervention (n = 46) groups, all but 1 completed the trial. There were no differences in volume changes of ACC (0.01 [98.75% CI, -0.02 to 0.05]; P = .36) or insula (0.01 [98.75% CI, -0.02 to 0.03]; P = .58) between meditation and no intervention or non-native language training groups, respectively. Differences in perfusion changes did not reach statistical significance for meditation compared with no intervention in ACC (0.02 [98.75% CI, -0.01 to 0.05]; P = .06) or compared with non-native language training in insula (0.02 [98.75% CI, -0.01 to 0.05]; P = .09). Meditation was superior to non-native language training on 18-month changes in a global composite score capturing attention regulation, socioemotional, and self-knowledge capacities (Cohen d, 0.52 [95% CI, 0.19-0.85]; P = .002). The study findings confirm the feasibility of meditation and non-native language training in elderly individuals, with high adherence and very low attrition. Findings also show positive behavioral effects of meditation that were not reflected on volume, and not significantly on perfusion, of target brain areas. ClinicalTrials.gov Identifier: NCT02977819.

Identifiants

pubmed: 36215061
pii: 2796818
doi: 10.1001/jamaneurol.2022.3185
pmc: PMC9552046
doi:

Banques de données

ClinicalTrials.gov
['NCT02977819']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1165-1174

Investigateurs

Florence Allais (F)
Claire André (C)
Eider M Arenaza Urquijo (EM)
Julien Asselineau (J)
Sebastian Baez Lugo (S)
Martine Batchelor (M)
Axel Beaugonin (A)
Alexandre Bejanin (A)
Pierre Champetier (P)
Gaël Chételat (G)
Anne Chocat (A)
Fabienne Collette (F)
Roxane Coueron (R)
Sophie Dautricourt (S)
Robin DE Flores (R)
Vincent DE LA Sayette (V)
Pascal Delamillieure (P)
Marion Delarue (M)
Yacila Deza Araujo (Y)
Francesca Felisatti (F)
Eglantine Ferrand Devouge (E)
Eric Frison (E)
Antoine Garnier Crussard (A)
Francis Gheysen (F)
Julie Gonneaud (J)
Marc Heidmann (M)
Thien Titi Huong Tran Dolma (TT)
Frank Jessen (F)
Olga Klimecki (O)
Pierre Krolak Salmon (P)
Elizabeth Kuhn (E)
Brigitte Landeau (B)
Gwendoline Le Du (G)
Valérie Lefranc (V)
Antoine Lutz (A)
Natalie Marchant (N)
Florence Mezenge (F)
Jose Luis Molinuevo (JL)
Inès Moulinet (I)
Valentin Ourry (V)
Cassandre Palix (C)
Léo Paly (L)
Géraldine Poisnel (G)
Stefano Poletti (S)
Anne Quillard (A)
Géraldine Rauchs (G)
Stéphane Rehel (S)
Florence Requier (F)
Eric Salmon (E)
Raquel Sanchez (R)
Corinne Schimmer (C)
Marco Schlosser (M)
Christine Schwimmer (C)
Siya Sherif (S)
Edelweiss Touron (E)
Matthieu Vanhoutte (M)
Denis Vivien (D)
Patrik Vuilleumier (P)
Cédrick Wallet (C)
Caitlin Ware (C)
Miranka Wirth (M)

Auteurs

Gael Chételat (G)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Antoine Lutz (A)

Lyon Neuroscience Research Center INSERM U1028, CNRS UMR5292, Lyon 1 University, Lyon, France.

Olga Klimecki (O)

Swiss Center for Affective Sciences, Department of Neuroscience, University of Geneva Medical School, Geneva, Switzerland.

Eric Frison (E)

EUCLID/F-CRIN Clinical Trials Platform, INSERM, CHU Bordeaux, University of Bordeaux, CIC1401-EC, Bordeaux, France.

Julien Asselineau (J)

EUCLID/F-CRIN Clinical Trials Platform, INSERM, CHU Bordeaux, University of Bordeaux, CIC1401-EC, Bordeaux, France.

Marco Schlosser (M)

Division of Psychiatry, University College London, London, United Kingdom.
Department of Psychology, Faculty of Psychology and Educational Sciences, University of Geneva, Geneva, Switzerland.

Eider M Arenaza-Urquijo (EM)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.
Barcelonabeta Brain Research Center, Fundación Pasqual Maragall, Barcelona, Spain.

Florence Mézenge (F)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Elizabeth Kuhn (E)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Inès Moulinet (I)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Edelweiss Touron (E)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Sophie Dautricourt (S)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Claire André (C)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Cassandre Palix (C)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Valentin Ourry (V)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Francesca Felisatti (F)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Julie Gonneaud (J)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Brigitte Landeau (B)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Géraldine Rauchs (G)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Anne Chocat (A)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Anne Quillard (A)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Eglantine Ferrand Devouge (EF)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.
Normandie Univ, UNIROUEN, Department of General Practice, Rouen, France.
Rouen University Hospital, CIC-CRB 1404, F 76000, Rouen, France.

Patrik Vuilleumier (P)

Swiss Center for Affective Sciences, Department of Neuroscience, University of Geneva Medical School, Geneva, Switzerland.

Vincent de La Sayette (V)

CHU Caen-Normandie, Department of Neurology, Caen, France.

Denis Vivien (D)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.
CHU Caen-Normandie, Department of Clinical Research, Caen, France.

Fabienne Collette (F)

GIGA-CRC, In Vivo Imaging, Université de Liège and Belgian National Fund for Scientific Research, Liège, Belgium.

Géraldine Poisnel (G)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Natalie L Marchant (NL)

Division of Psychiatry, University College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH